Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cholet
Clinical trial register · France

Clinical Trials in Cholet, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2823 Lyon 1395 Bordeaux 1389 Marseille 1291 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Angers14 UNICANCER4 Novartis Pharmaceuticals3 AstraZeneca3 Centre Hospitalier Intercommunal Creteil2
Site location
Paris2823 Lyon1395 Bordeaux1389 Marseille1291 Lille1281
All 809 locations
Target enrolment
to

Trials with a site in Cholet

58 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
University Hospital, Angers
Observational
5,760
Angers, Argenteuil, Brest, Chartres, Cholet, Clermont-Ferrand, Grenoble, Laval
2026-09-01
Recruiting
Eli Lilly and Company
Phase 2
606
Brest, Cholet, Créteil, La Tronche, Lyon, Marseille, Montpellier, Paris
2026-08-07
Recruiting
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
NCT07499661Acute Heart Failure (AHF), Pulmonary Embolism (Diagnosis), Venous Thromboembolism
University Hospital, Angers
Not applicable
740
Agen, Angers, Brest, Chambray-lès-Tours, Cholet, Clermont-Ferrand, La Tronche, Lyon
2026-07-15
Recruiting
Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
NCT07455942Squamous Cell Carcinoma of the Anal Canal, HPV-induced Cancer
Centre Hospitalier Intercommunal Creteil
Observational
300
Angers, Avignon, Bayonne, Beuvry, Château-Gontier, Cholet, Créteil, Épagny
2026-06-23
Not yet open
University Hospital, Brest
Not applicable
246
Angers, Bordeaux, Brest, Cholet, La Roche-sur-Yon, Lorient, Nantes, Paris
2026-06-01
Not yet open
University Hospital, Angers
Not applicable
568
Angers, Argenteuil, Brest, Cholet, Clermont-Ferrand, Colombes, Grenoble, Le Mans
2026-06
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Bayonne, Bordeaux, Brest, Chambray-lès-Tours, Cholet, La Rochelle, Le Chesnay, Le Coudray
2026-05-11
Recruiting
SAPHIR2 : Simplification of PHysical Activity Assessment by Rapid Interrogation
NCT07147608General Population (no Specific Condition or Disease)
University Hospital, Angers
Observational
118
Angers, Cholet, Le Mans
2025-12-19
Recruiting
University Hospital, Brest
Phase 3
140
Aix-en-Provence, Arras, Besançon, Bordeaux, Brest, Caen, Cholet, Clermont-Ferrand
2025-12-18
Recruiting
Eli Lilly and Company
Phase 2
531
Aix-en-Provence, Brest, Cholet, Le Chesnay, Le Kremlin-Bicêtre, Montfermeil, Paris, Pessac
2025-10-22
Recruiting
University Hospital, Angers
Not applicable
3,084
Chesnay, Angers, Caen, Cholet, La Roche-sur-Yon, La Rochelle, Le Coudray, Rouen
2025-09-19
Recruiting
AstraZeneca
Phase 3
800
Avignon, Besançon, Bordeaux, Chambray-lès-Tours, Cholet, Créteil, Grenoble, Lille
2025-08-01
Recruiting
University Hospital, Angers
Observational
3,000
Angers, Cholet, Saumur
2025-07-25
Recruiting
Pfizer
Phase 3
714
Pessac, Quimper, Toulouse, Rennes, Montpellier, Saint-Herblain, Cholet, Toulon
2025-07-23
Recruiting
Institut Cancerologie de l'Ouest
Not applicable
63
Angers, Cholet, Saint-Herblain
2025-05-15
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Béziers, Cholet, Grenoble, Lille, Montpellier, Paris, Pessac, Poitiers
2025-04-30
Recruiting
University Hospital, Angers
Observational
200
Angers, Cholet, Le Mans
2025-04-15
Recruiting
UNICANCER
Phase 2
73
Amiens, Angers, Avignon, Besançon, Cholet, Dijon, Lyon, Montpellier
2025-03-21
Recruiting
University Hospital, Angers
Not applicable
20
Angers, Cholet, Laval, Rennes, Vannes
2025-03-19
Recruiting
Tight Control for Rotator Cuff Tendinopathy
NCT06517680Rotator Cuff Tendinopathy
Nantes University Hospital
Not applicable
156
Angers, Brest, Chambray-lès-Tours, Cholet, La Roche-sur-Yon, Le Mans, Nantes, Rennes
2024-11-25
Active, closed
University Hospital, Angers
Not applicable
607
Amiens, Angers, Bordeaux, Brest, Bron, Caen, Chalon-sur-Saône, Cholet
2024-11-11
Recruiting
Centre Hospitalier le Mans
Not applicable
2,400
Angers, Cholet, Grenoble, La Roche-sur-Yon, Le Mans, Marseille, Nantes, Orléans
2024-11-07
Recruiting
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
NCT05486884Cardiac Arrest, Out-of-hospital Cardiac Arrest (OHCA)
Centre Hospitalier le Mans
Not applicable
1,380
Montpellier, Brest, Brive-la-Gaillarde, Caen, Cannes, Cholet, Dieppe, Dijon
2024-09-28
Recruiting
RAT-HEMATO : Return to Work After Malignant Hemopathy
NCT06262789Leukemia, Lymphoma, Multiple Myeloma
University Hospital, Angers
Not applicable
264
Angers, Brest, Caen, Cholet, Montivilliers, Morlaix, Rennes, Rouen
2024-09-27
Recruiting
Nantes University Hospital
Observational
300
Nantes, Cholet, Laval, Le Mans, Orléans
2024-08-03
Recruiting
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
NCT06195540Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism, Lower Limb Trauma
DrugRivaroxaban
University Hospital, Angers
Phase 3
1,424
Agen, Angers, Argenteuil, Arpajon, Caen, Chambray-lès-Tours, Cholet, Clermont-Ferrand
2024-07-19
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Toulon, Brest, Cholet, Colmar, Dijon, Le Mans, Nantes, Reims
2024-06-28
Recruiting
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
NCT06361641Myeloproliferative Neoplasm, Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis
University Hospital, Angers
Not applicable
70
Angers, Cholet, Saumur
2024-05-29
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
120
Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Cholet, Clermont-Ferrand
2024-04-16
Recruiting
AstraZeneca
Phase 3
3,850
Béziers, Bron, Caen, Cholet, Créteil, Dijon, La Roche-sur-Yon, La Tronche
2024-04-12
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Besançon, Cholet, Créteil, Lille, Marseille, Montpellier, Paris, Pessac
2024-02-21
Recruiting
Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care
NCT06104956Acute Hypoxemic Respiratory Failure, High-flow Nasal Oxygen Therapy
University Hospital, Tours
Not applicable
370
Blois, Bourg-en-Bresse, Bourges, Caen, Chartres, Cholet, Dax, Le Mans
2024-02-17
Recruiting
Federation Francophone de Cancerologie Digestive
Observational
600
Bayonne, Beauvais, Besançon, Boujan-sur-Libron, Boulogne-sur-Mer, Chambéry, Cholet, Compiègne
2024-02-12
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
628
Amiens, Angers, Béthune, Bobigny, Bordeaux, Boulogne-Billancourt, Cholet, Clermont-Ferrand
2023-10-19
Not yet open
Assessment and Prevention of Caregiver Burden in Oncology
NCT05750836Oncology, Caregiver Burden
Institut Cancerologie de l'Ouest
Not applicable
250
Cholet, Nice, Rouen, Saint-Herblain, Saint-Lô
2023-07
Active, closed
UNICANCER
Phase 2
118
Amiens, Arras, Avignon, Beauvais, Besançon, Brest, Cholet, Clermont-Ferrand
2023-06-23
Recruiting
University Hospital, Angers
Not applicable
50
Angers, Brest, Cholet, Créteil, Marseille, Nantes, Paris, Pessac
2023-04-24
Recruiting
AstraZeneca
Phase 3
4,300
Angers, Argenteuil, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Cholet, Clermont-Ferrand
2023-03-31
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Avignon, Brest, Caen, Chambray-lès-Tours, Cholet, Contamine-sur-Arve, Lyon, Nantes
2022-12-16
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Cholet, Créteil
2022-10-27
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
2022-10-04
Recruiting
Centre Hospitalier Intercommunal Creteil
Not applicable
820
Amiens, Angers, Argenteuil, Belfort, Cholet, Créteil, Dijon, Grenoble
2022-10-01
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
1,100
Avignon, Bayonne, Besançon, Blois, Caen, Cholet, Clermont-Ferrand, Dijon
2022-05-03
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
390
Angers, Avignon, Besançon, Bordeaux, Brest, Bron, Caen, Cholet
2022-02-01
Active, closed
Rennes University Hospital
Phase 3
106
Rennes, Amiens, Bordeaux, Caen, Cholet, Grenoble, Mulhouse, Nîmes
2021-11-24
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Limoges, Amiens, Béziers, Brest, Chambray-lès-Tours, Cholet, Clermont-Ferrand, Corbeil-Essonnes
2021-11-23
Recruiting
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
NCT04942080Myeloproliferative Neoplasm, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage, Primary Myelofibrosis, Fibrotic Stage
University Hospital, Angers
Not applicable
260
Angers, Bordeaux, Brest, Cholet, Le Mans, Morlaix, Paris, Poitiers
2021-10-28
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
105
Avignon, Cholet, Mulhouse, Strasbourg
2021-10-12
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bobigny, Cholet, Clermont-Ferrand, Créteil, Échirolles, Lille, Lyon, Nice
2021-08-25
Active, closed
ARCAGY/ GINECO GROUP
Phase 2
180
Angers, Avignon, Bayonne, Besançon, Bordeaux, Caen, Chambray-lès-Tours, Cholet
2021-08-05
Recruiting
Unity Health Toronto
Not applicable
740
Amiens, Angers, Argenteuil, Beauvais, Bordeaux, Brest, Cholet, Créteil
2020-11-23
Recruiting
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase 4
238
Cholet, Amiens, Besançon, Caen, Clermont-Ferrand, Clichy, Colmar, Douai
2020-01-14
Active, closed
UNICANCER
Not applicable
200
Angers, Avignon, Caen, Chalon-sur-Saône, Cholet, Clermont-Ferrand, Dijon, Lyon
2019-10-23
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Avignon, Bordeaux, Caen, Cholet, Dijon, Limoges, Lorient, Lyon
2019-08-27
Active, closed
Tesaro, Inc.
Phase 3
1,400
Angers, Avignon, Besançon, Bordeaux, Bron, Caen, Cholet, Clermont-Ferrand
2018-10-11
Active, closed
QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program
NCT03169075Home Based Standardised Adapted Physical Activity Programme, Patients Taking Oral Targeted Therapy for Metastatic Cancer
UNICANCER
Not applicable
190
Angers, Annecy, Besançon, Caen, Cholet, Grenoble, La Roche-sur-Yon, Lyon
2017-07-11
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Angers, Avignon, Bordeaux, Caen, Cholet, Clermont-Ferrand, Dijon, Lille
2017-06-21
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Pessac, Toulouse, Saint-Herblain, Saint-Nazaire, Angers, Cholet, Lorient, Lille
2016-09-13
Rows per page Showing 1–58 of 58
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-france/city/cholet

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 58 of those studies with a site in Cholet.

How many clinical trials are recruiting in Cholet?

37 of the 58 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 4 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cholet), 58 studies
PhaseStudiesRecruitingShare
Not applicable211536.2%
Phase 317929.3%
Phase 210517.2%
Observational9715.5%
Phase 4111.7%

Most active sponsors

Lead sponsors with the most studies (Cholet)
Lead sponsorStudiesRecruiting
University Hospital, Angers1411
UNICANCER41
AstraZeneca33
Novartis Pharmaceuticals30
ARCAGY/ GINECO GROUP21
Centre Hospitalier Intercommunal Creteil22
Centre Hospitalier le Mans22
Eli Lilly and Company22
EMD Serono Research & Development Institute, Inc.21
Institut Cancerologie de l'Ouest21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.